Ligand validation:2GOU

FMN: FLAVIN MONONUCLEOTIDE

FMN is a Ligand Of Interest in 2GOU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2GOU_FMN_A_4401	94%	13%	0.077	0.978	2.61	1.38	10	5	0	0	100%	1
4AWT_FMN_A_500	99%	42%	0.055	0.994	1.21	1.03	1	3	0	0	100%	1
2GQA_FMN_A_1401	99%	14%	0.054	0.984	2.18	1.74	11	8	0	0	100%	1
4AWS_FMN_A_500	98%	56%	0.071	0.994	0.97	0.72	1	-	0	0	100%	1
2GQ8_FMN_A_1401	96%	5%	0.068	0.975	3.05	2.35	13	15	0	0	100%	1
4AWU_FMN_A_500	92%	43%	0.084	0.975	0.97	1.23	2	6	0	0	100%	1
4XHF_FMN_C_300	100%	16%	0.024	0.995	2.46	1.29	11	6	0	0	100%	0.9677
1QXO_FMN_D_4004	100%	27%	0.025	0.993	1.24	1.7	2	15	1	0	100%	1
5LJI_FMN_A_201	100%	27%	0.025	0.995	1.62	1.33	5	5	0	0	100%	1
9DHH_FMN_A_401	100%	35%	0.026	0.994	1.4	1.19	5	5	0	0	100%	1
8J4W_FMN_C_201	100%	43%	0.031	0.992	1.08	1.12	2	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.